Medicine & Health

A new, artificial intelligence-based method of analyzing mammograms, developed by researchers at WashU Medicine, identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did.

Results from a clinical trial conducted at WashU Medicine showed adding the investigational drug itacitinib to standard care for “half-matched” stem cell transplantation may reduce rates of graft-versus-host disease.

Fructose is a sweetener added to ultra-processed foods, typically in the form of high-fructose corn syrup. WashU research shows that the liver turns fructose into lipids that many types of cancers crave.

Siteman Cancer Center’s new building for outpatient care will be named the Gary C. Werths Building. A transformative commitment by the late Werths and his husband, Richard Frimel, will support cancer research and medical student scholarships.

The Siteman Blood Cancer Center delivers tomorrow’s treatments today.

At the forefront of individualized cancer care.

Getting a head start on detection and treatment in adults under 50.

Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.

A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.